bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Update

bioMérieux S.A. (OTCMKTS:BMXMF) saw a large decrease in short interest in December. As of December 31st, there was short interest totalling 118,300 shares, a decrease of 19.1% from the December 15th total of 146,200 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 1,183.0 days.

bioMérieux Stock Performance

Shares of bioMérieux stock remained flat at $110.92 during mid-day trading on Thursday. The company’s 50 day simple moving average is $105.25 and its 200-day simple moving average is $108.70. bioMérieux has a 1 year low of $93.50 and a 1 year high of $122.52.

bioMérieux Company Profile

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.